Jennifer E. Miller, PhD
Assistant Professor – Division of Medical Ethics
Jennifer E. Miller, PhD, is an Assistant Professor in the Division of Medical Ethics and Department of Population Health at NYU School of Medicine. Prior to joining NYU’s faculty, Dr. Miller was a fellow in Harvard University’s Edmond J. Safra Center for Ethics and taught at Duke University’s Kenan Institute for Ethics and Fuqua School of Business as the George C. Lamb Regulatory Governance fellow, Fordham University's Graduate School of Business, and Columbia University's Bioethics and Cross Cultural Education Program. She is also the founding President of the nonprofit, Bioethics International.
Dr. Miller serves on NYU’s Pharmacy and Therapeutic Committee (P&T), Stem Cell Research Oversight IRB, and Electronic Medical Records Working Group. She is also a monitor for J&J-NYU’s Compassionate-Use Advisory Committee (CompAC). Previously, Dr. Miller served on the Center for Disease Control and Prevention’s (CDC) Task Force for Pediatric Emergency Mass Critical Care, the American Medical Association’s (AMA) Advanced Disaster Life Support Education Consortium, the United Nations Economic and Social Council, and the Patient-Centered Outcomes Research Institute (PCORI) National Institutes of Health (NIH) Collaboratory.
A prolific writer and speaker, Dr. Miller has authored over 35 publications, including for Nature Medicine, Health Affairs, the Hastings Center Report, The Scientist, the Journal of Law, Medicine, and Ethics, The American Journal of Bioethics, Cambridge Quarterly of Healthcare Ethics, Pediatric Critical Care Medicine, The Journal of Prehospital and Disaster Medicine, and the Journal of the Society for Clinical Trials. She was a Fox News pundit from 2009 to 2012 and remains a commentator for print, radio and television news media, frequently featured in CBS news, Wall Street Journal, Washington Post, Bloomberg News, and NPR.
Dr. Miller’s current work addresses the ethics and governance of healthcare innovation, focusing on how clinical trials are designed and conducted, data-sharing, drug marketing, and the accessibility of medicines. Dr. Miller created an index (The Good Pharma Scorecard) that ranks pharmaceutical companies and new drugs on their ethics and public health performance to help recognize best practices in companies, improve trustworthiness, and incentivize reform where needed.
Dr. Miller is from Ridgefield, Connecticut. She completed a BS in physics from Fordham University, a Doctorate in bioethics from the Pontifical System, and Post-doctorates in institutional corruption and regulatory governance at Duke University and Harvard University.